Friday 23 March 2018

UDG Healthcare operating profit jumps to €53.6m

United Drug Chief Executive Liam FitzGerald
United Drug Chief Executive Liam FitzGerald reporters

Irish health company UDG Healthcare saw its operating profit grow by 19pc to €53.6m, its latest half year results have shown.

In the six months to the end of March the firm also saw its profit before tax increase by 26pc, or 15pc on a constant currency basis, to €46.6m.

Revenue at the firm hit just over €1.1bn, a 9pc increase on the same period the year before.

The company has also upped its growth range for earnings per share from the previously forecast 5pc-8pc growth to a range of 7pc-9pc.

Commenting on the 2015 interim performance, UDG Healthcare Chief Executive Officer, Liam FitzGerald said: “The first half of 2015 has been a period of further strong advancement for the group as our strategy to expand into higher growth areas continued to deliver robust profit growth.

“Our two growth platforms, Sharp and Ashfield, accounted for over 70pc of the Group’s operating profit in the period and in aggregate increased profits by 55pc.

Online Editors

Business Newsletter

Read the leading stories from the world of Business.

Also in Business